Status: Recruiting
Using CircuLating Tumor DNA to Risk Adapt Post-Operative Therapy for HPV-associated Oropharyngeal Cancer
This is a single institution phase II study that will enroll patients with T0-3N0-2 p16-positive oropharyngeal squamous cell carcinoma (OSCC) undergoing resection of all gross visible disease at the primary site and in the lymph nodes.
Participants needed: 50
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Zachary ZumstegUpdated: May 8, 2026Locations: 4
Eligibility criteria
AJCC 8th edition T0-3N0-2 p16-positive oropharyngeal (tonsil, base of tongue, gl... [+23]
AJCC 8th edition pT4 or cN3 disease. [+15]